CClinicalTrials.gg
RecruitingNCT06050772Updated Sep 22, 2023

Effect of Immersive Virtual Reality Reminiscence Versus Traditional Reminiscence Therapy on Cognitive Function and Psychological Wellbeing Among Institutionalized Older Adults: A Randomized Controlled Trial

An interventional study of Immersive Virtual Reality Reminiscence and Traditional Reminiscence Therapy in Institutionalized Older Adults, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 60 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-09-22.

Sponsored by Alexandria University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Mar 2023, registered Sep 2023).
  • Started Mar 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
60 Years to 90 Years
Sex
All
01

Study summary

Cognitive function and psychological wellbeing are basic determinants of successful ageing that enable older adults to maintain their health, independence, and autonomy. Reminiscence therapy (RT) is one of the most prevalent evidence-based psychosocial interventions that can enhance older adults' cognitive function and maintain their psychological health. Virtual reality (VR) reminiscence is an innovative strategy that has the advantage of integrating technology in to the care of institutionalized older adults. However, limited researches have been conducted to compare the role of VR reminiscence versus traditional RT on improving older adult's cognitive and psychological wellbeing.

Read the detailed description

The aim of this study is to determine the effect of virtual reality reminiscence versus traditional reminiscence therapy on cognitive function and psychological wellbeing among institutionalized older adults.

02

Conditions studied

  • Institutionalized Older Adults
03

In context

Lead sponsor

Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • their age is 60 years and above, capable of communicating clearly, free form hearing or vision impairments that might hinder RT, and being able to tolerate using the Head Mounted Display(HMD) headset.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    STUDY GROUP

    Groups who will receive virtual reality reminiscence versus traditional reminiscence therapy to determine its effect on cognitive function and psychological wellbeing.

    Behavioral: Immersive Virtual Reality Reminiscence · Behavioral: Traditional Reminiscence Therapy

  • No intervention
    Control group

    Groups who will not receive any intervention

Interventions

  • BehavioralImmersive Virtual Reality Reminiscence

    a computer-generated environment using head-mounted displays (HMDs) that provide a fully immersive, completely engaging, and realistic experience so that users feel like they are a part of the virtual world

  • BehavioralTraditional Reminiscence Therapy

    RT is a technique that encourages older adults' positive emotions and coping mechanisms by using the recall of earlier memories and the sharing of life experiences.

06

What researchers measure

Primary outcomes

  1. cognitive function

    The Mini-Mental State Examination (MMS) is recommended as an effective predictor of cognitive function of the elderly people . It involves six cognitive related subscales with eleven questions investigating memory, concentration, orientation to time and place, registration, calculation, repetition, naming objects, language and recall.

    Time frame: 3 months

  2. Psychological Wellbeing

    The PWB measures six dimensions of psychological wellbeing among older adults including autonomy, environmental mastery, personal development, supportive relationships, purpose in life, and acceptance of oneself

    Time frame: 3 months

  3. Virtual Reality

    The CSQ-VR is a widely used scale to assess side effects of VR due to several advantages; it is easy applicable tool, it has clear questions and answers, its coring is simple and easy to understand, and its items cover all VR related symptoms.

    Time frame: 3 months

  4. Immersive Virtual Reality

    This questionnaire was adapted from the User eXperience in Immersive Virtual Environment Questionnaire (UX in IVEQ). It was used to assess the participant's experience in immersive VR. It is made up of 16 items which are distributed across 5 domains including presence (4 items), engagement (3 items), immersion (3 item), flow (3 items), and emotion (3 items).

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of Nursing, Damnhour university
    Damanhūr, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06050772
Lead sponsor
Alexandria University
Responsible party
Mahmoud Khedr (Lecturer, Alexandria University) — Principal investigator
First posted
Sep 22, 2023
Start date
Mar 20, 2023
Primary completion
Sep 25, 2023 (estimated)
Completion
Oct 1, 2023 (estimated)
Last update
Sep 22, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion